908 Devices SVP McCallion reports equity holdings
908 Devices Inc. executive Kevin J. McCallion, SVP of Products and Production, filed an initial ownership report detailing his equity in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
908 Devices Inc. executive Kevin J. McCallion, SVP of Products and Production, filed an initial ownership report detailing his equity in the company. He holds several stock option awards, including one covering 42,014 shares, restricted stock units covering 58,602 shares, and 44,925 shares of common stock, all held directly. Footnotes explain multi‑year vesting schedules for the options and RSUs, with key vesting dates beginning February 1, 2024 and extending through February 1, 2027, generally conditioned on his continued service.
Insider Trade Summary
11 transactions reported
Mixed
11 txns
Insider
McCallion Kevin J.
Role
SVP, Products and Production
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 195,623 contracts (Direct);
Restricted Stock Units — 128,673 contracts (Direct);
Common Stock — 44,925 shares (Direct)
Footnotes (9)
- F1. The shares underlying the option are fully vested and immediately exercisable.
- F2. Twenty-five percent of the shares underlying the option became vested and exercisable on February 1, 2024, and the remaining 75% of the shares underlying the option became or will become vested and exercisable in substantially equal monthly installments over the 36 months following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date.
- F3. Twenty-five percent of the shares underlying the option became vested and exercisable on February 1, 2025, and the remaining 75% of the shares underlying the option became or will become vested and exercisable in substantially equal monthly installments over the 36 months following February 1, 2025, subject to the reporting person's continued service through the applicable vesting date.
- F4. One-third of the shares underlying the option became vested and exercisable on February 1, 2026, and the remaining two-thirds of the shares underlying the option became or will become vested and exercisable in substantially equal monthly installments over the 24 months following February 1, 2026, subject to the reporting person's continued service through the applicable vesting date.
- F5. One-third of the shares underlying the option become vested and exercisable on February 1, 2027, and the remaining two-thirds of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 24 months following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date.
- F6. These restricted stock units ("RSUs") vest on February 1, 2027, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
- F7. Each RSU represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
- F8. These RSUs vest in two substantially equal annual installments at the two anniversary dates following February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
- F9. These RSUs vest in three substantially equal annual installments at the three anniversary dates following February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Kevin J. McCallion Form 3 filing for 908 Devices (MASS) show?
The Form 3 shows Kevin J. McCallion’s initial equity holdings in 908 Devices. It lists multiple stock option grants, restricted stock units, and 44,925 shares of common stock, all held directly, along with detailed vesting schedules tied to future service dates.
What stock options does Kevin J. McCallion hold in 908 Devices (MASS)?
He holds several stock option awards, including one with 42,014 underlying shares and others with 37,801 and 40,011 shares. Footnotes describe vesting that began on February 1, 2024, 2025, and 2026, with remaining portions vesting monthly over 24–36 months, subject to continued service.
What restricted stock units (RSUs) are reported for Kevin J. McCallion at 908 Devices (MASS)?
The Form 3 lists multiple RSU awards, including one covering 58,602 shares and others for 48,466 and 15,376 shares. Footnotes state these RSUs vest in one to three annual installments starting February 1, 2026 or 2027 and convert into common stock when vested.
What are the key vesting dates in Kevin J. McCallion’s equity awards at 908 Devices (MASS)?
Key vesting reference dates are February 1, 2024, 2025, 2026, and 2027. Options and RSUs generally vest either 25% or one‑third on these dates, with remaining portions vesting monthly or annually over 24–36 months, conditioned on his continued service with the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates